Autologous Lens Capsule Flap Transplantation for Persistent Macular Holes

Table 1

Patients’ data.

Patient no.	Sex/age	MH etiology	BCVA before the primary surgery (Snellen)	BCVA before lens capsule transplant surgery (Snellen)	Final BCVA post-op. (Snellen)	MH (min/basal) before the primary surgery (Snellen)	MH (min/basal) before LCTFS (µm)	Transplant	Previous surgical procedures/primary pathology
1	F/43	Primary	0, 1; 20/200	0, 1; 20/200	0, 2; 20/100	936/1705	951/1396	Posterior capsule	(1) Phacovitrectomy + sil.oil/MH
2	F/68	Primary	0, 1; 20/200	0, 1; 20/200	0, 16; 20/125	605/1020	603/1017	Posterior capsule	(1) Vitrectomy + 100%air/MH
3	F/60	Primary	0, 1; 20/200	0, 06; 20/320	0, 16; 20/125	905/1508	1065/1611	Posterior capsule	(1) Vitrectomy + ILM peeling + sil. oil/MH with retinal detachment; (2) Sil. oil removal/persistent MH
4	F/59	Secondary (after blunt trauma)	0, 03; 20/640	0, 1; 20/200	0, 2; 20/100	582/647	445/600	Posterior capsule	(1) Phacovitrectomy + 100% air/MH
5	F/73	Primary	0, 1; 20/200	0, 16; 20/125	0, 16; 20/125	389/1150	270/808	Anterior capsule	(1) Vitrectomy + 100% air/MH

F: female; BCVA: best-corrected visual acuity; MH: macular hole; LCTFS: lens capsular flap transplantation surgery; No.: number; sil. ol: silicone oil.